홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → N-(4'-Amino-5'-methylspiro[chroman-4,2'-imidazole]-6-yl)-5-chloropicolinamide

HRID 1965085
인쇄

반응식

HRID 1965085 반응식
Cl.CN(C)CCCN=C=NCC.[Cl:13][C:14]1[CH:15]=[CH:16][C:17]([C:20]([OH:22])=O)=[N:18][CH:19]=1.[CH3:23][C:24]1[C:25]([NH2:39])=[N:26][C:27]2([C:37]3[C:32](=[CH:33][CH:34]=[C:35]([NH2:38])[CH:36]=3)[O:31][CH2:30][CH2:29]2)[N:28]=1.Cl>C(Cl)Cl.CN(C=O)C>[NH2:39][C:25]1[C:24]([CH3:23])=[N:28][C:27]2([C:37]3[C:32](=[CH:33][CH:34]=[C:35]([NH:38][C:20](=[O:22])[C:17]4[CH:16]=[CH:15][C:14]([Cl:13])=[CH:19][N:18]=4)[CH:36]=3)[O:31][CH2:30][CH2:29]2)[N:26]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 313Hydrochloric AcidHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 27628725-Chloro-2-picolinic acidHCID 679794075'-Methylspiro[chromane-4,2'-imidazole]-4',6-diamine2회

생성물 1

HCID 57385111N-(4'-Amino-5'-methylspiro[chroman-4,2'-imidazole]-6-yl)-5-chloropicolinamide수율 31.7%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매

실험 절차

N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (58 mg, 0.30 mmol) was added to a suspension of 5-chloropyridine-2-carboxylic acid (37 mg, 0.23 mmol) in DCM (1.5 mL). The obtained solution was stirred for 10 min and added dropwise over 2 min to an ice-cooled solution of 5′-methylspiro[chroman-4,2′-imidazole]-4′,6-diamine (Intermediate 30, 54 mg, 0.23 mmol) and 2 M HCl (0.117 mL, 0.23 mmol) in DMF (1.5 mL). The mixture was stirred at 0° C. for 5 min. Volatiles were removed in vacuo, and the residue was purified by preparative chromatography. Fractions containing the product were combined, and the organic solvent was removed in vacuo. The aqueous residue was alkalized with (sat) NaHCO3 and then extracted twice with EtOAc. The combined organic phases were dried (Na2SO4) and evaporated to give a product which was purified by flash chromatography (4 g, gradient elution (EtOAc/MeOH/conc. NH3) in heptane) affording the title compound (27 mg, 31% yield). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.92 (br. s., 2 H), 2.23 (s, 3 H), 4.23-4.54 (m, 2 H), 6.56 (br. s., 2 H), 6.80 (d, 1 H), 7.05 (br. s., 1 H), 7.54-7.72 (m, 1 H), 8.04-8.12 (m, 1 H), 8.13-8.23 (m, 1 H), 8.72 (br. s., 1 H), 10.41 (s, 1 H); HPLC, MS (APCI1) m/z 370 [M+H]1.

후처리

  1. stirringThe mixture was stirred at 0° C. for 5 min
  2. customVolatiles were removed in vacuo
  3. customthe residue was purified by preparative chromatography
  4. additionFractions containing the product
  5. customthe organic solvent was removed in vacuo
  6. extractionextracted twice with EtOAc
  7. dry with materialThe combined organic phases were dried (Na2SO4)
  8. customevaporated
  9. customto give a product which
  10. customwas purified by flash chromatography (4 g, gradient elution (EtOAc/MeOH/conc. NH3) in heptane)

출처 및 근거

ORD 기록
ord-3b94e9ad3cbe4e7e85a014ab91f43662
출처 데이터셋
uspto-grants-2013_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08415483B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트